Alnylam Pharmaceuticals, Inc. (ALNY)
Alnylam Pharmaceuticals, Inc. is listed on Nasdaq (ALNY) in the Healthcare sector. Prices from Yahoo Finance with their delay; analysis computed from daily price history.
All stocks — US stocks · Heatmap
- Exchange
- Nasdaq · Closed Opens in 22h 00m
- Data delay
- 15 min
- Day range
- 154.30 – 159.45
- Prev. close
- 156.66
Key statistics
- Open
- 155.22
- Previous close
- 156.66
- 52-week range
- 154.30 – 479.79
- Volume
- 2.8M
- Avg volume (3M)
- 1.9M
- Market cap
- 20.9B USD
- P/E (TTM)
- 7.9
- EPS (TTM)
- 19.80
- Dividend yield
- 0.00%
- Sector
- Healthcare Biotechnology
- Listed in
- Nasdaq-100
- Currency
- USD
Chart
Movement expectation (statistical)
Ranges the price would stay in with a given probability if its recent volatility continues.
| Horizon | ≈68% range (±1σ) | ≈95% range (±2σ) | Past fit |
|---|---|---|---|
| Next trading day | 148.90 – 163.31 ±4.73% | 142.18 – 171.03 | 93% / 99% of the last 250 periods stayed inside |
| Next 5 trading days | 140.64 – 172.91 ±10.88% | 126.84 – 191.72 | 90% / 96% of the last 251 periods stayed inside |
ATR range (Next trading day): 144.59 – 167.29 · (Next 5 trading days): 130.57 – 181.31
Daily volatility (σ, 60 days): 4.62%. Basis: close of 2026-11-06 and current price.
⚠️ These are statistical ranges calculated from the stock's own past volatility. They are not a price target, a forecast or a recommendation to buy or sell. Prices can and do move outside them, especially around earnings and news.
Trend reading
Downtrend A description of the indicators, not a recommendation.
- Price is below its 200-day average: the long-term trend is down.
- The 50-day average is below the 200-day (death-cross structure).
- Short term: below both the 20- and 50-day averages.
- RSI 21.8: oversold zone (below 30).
- MACD is below its signal line (negative momentum).
- 67.9% below the 52-week high.
Pivot points
| Classic | Fibonacci | |
|---|---|---|
| R3 | 163.98 | 161.71 |
| R2 | 161.71 | 159.75 |
| R1 | 158.83 | 158.53 |
| P | 156.56 | 156.56 |
| S1 | 153.68 | 154.60 |
| S2 | 151.41 | 153.38 |
| S3 | 148.53 | 151.41 |
From the 2026-11-06 daily bar (H 159.45 · L 154.30 · C 155.94)
Moving averages
| Moving averages | Price | MA signal |
|---|---|---|
| SMA20 | 201.40 | Below |
| SMA50 | 226.95 | Below |
| SMA200 | 279.38 | Below |
| EMA20 | 191.64 | Below |
| EMA50 | 217.21 | Below |
MA signal: Strong sell · RSI (14): 21.8 · 1M volatility (ann.): 104.3%
Performance
MACD (12, 26, 9)
- MACD
- -21.503
- Signal
- -16.094
- Histogram
- -5.410
- ATR (14)
- 11.35
Position in the sector heatmap
Today #36 of 61 Healthcare stocks in US by change; sector average -0.05%.
Sector peers
Largest Healthcare stocks in US by market cap
| Eli Lilly and CompanyLLY | 1,354.00 USD | -0.79% | 3.6M | 1.21T USD | Healthcare |
|---|---|---|---|---|---|
| Johnson & JohnsonJNJ | 276.22 USD | +1.43% | 8.9M | 664.9B USD | Healthcare |
| AbbVie Inc.ABBV | 291.31 USD | +1.07% | 5M | 514.9B USD | Healthcare |
| Merck & Co., Inc.MRK | 146.73 USD | -0.14% | 7.5M | 361.7B USD | Healthcare |
| UnitedHealth Group IncorporatedUNH | 394.15 USD | -0.40% | 5.8M | 353.2B USD | Healthcare |
| Thermo Fisher Scientific Inc.TMO | 694.76 USD | +2.63% | 2.1M | 257.4B USD | Healthcare |
| Amgen Inc.AMGN | 460.42 USD | +0.03% | 2.6M | 249B USD | Healthcare |
| Gilead Sciences, Inc.GILD | 166.89 USD | -0.41% | 5.7M | 207B USD | Healthcare |
| Abbott LaboratoriesABT | 109.93 USD | -3.23% | 8.2M | 190.4B USD | Healthcare |
| Pfizer Inc.PFE | 29.39 USD | -0.20% | 48.2M | 167.5B USD | Healthcare |
| Danaher CorporationDHR | 230.25 USD | +1.73% | 3.7M | 162B USD | Healthcare |
| Intuitive Surgical, Inc.ISRG | 452.80 USD | -3.36% | 2.1M | 157B USD | Healthcare |
| Alnylam Pharmaceuticals, Inc.ALNY | 155.94 USD | -0.46% | 2.8M | 20.9B USD | Healthcare |
Delays: NYSE 20 min · Nasdaq 15 min